市场调查报告书
商品编码
1511239
全球医疗特种袋市场,预测到 2030 年:按产品类型、材料类型、应用、最终用户和地区Medical Specialty Bags Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球医疗特种袋市场规模将达到 73 亿美元,预计到 2030 年将达到 109 亿美元,预测期内复合年增长率为 7.0%。
医用特殊袋是用于医疗环境中收集、储存和运输各种医用液体、检体和废弃物的专用容器。这些袋子在患者照护、感染控制和医疗程序中发挥重要作用。常见类型的特殊医疗袋包括用于静脉输液和药物的静脉输液袋、用于收集尿液和其他体液的引流袋、用于管理造口手术废物的造口袋以及用于收集和储存的捐血袋和样本袋。
据世界卫生组织(WHO)称,全世界每年捐献1.2亿单位的捐血,这些血液储存和输血活动都需要血袋。
慢性病负担增加
慢性病通常需要持续的管理和治疗,导致居家医疗解决方案的需求增加。特殊医疗袋,例如静脉输液袋、造口袋和引流袋,透过促进液体管理、废物管理和症状缓解,在居家照护中发挥重要作用。随着越来越多的患者选择居家照护来治疗慢性病,对特种医疗包的需求也随之成长。
成本问题和报销限制
报销限制和成本问题可能会影响患者获得基本医疗专业包,特别是患有慢性病或复杂医疗需求的患者。当医疗保健机构因财务限製而无法购买或采购必要的专用包时,患者可能会遇到延迟或次优的护理,或无法获得所需的医疗干预措施,并可能导致健康结果受损。
提高居家医疗的意识和接受度
远端医疗和远端监控技术的引入进一步促进了居家照护。专用医疗包使远距医疗保健提供者能够远端监测患者生命体征、给药和收集诊断样本,以支持远端医疗倡议的扩展,并改善该地区服务不足的人群获得医疗保健的机会。
处置挑战和环境问题
处置挑战和环境问题可能会限制医疗特种袋市场的研发和创新投资。如果製造商认为市场需求和盈利有限,他们可能不愿意引入环保替代品或投资永续产品设计和材料,从而阻碍市场成长和创新。
COVID-19 的影响
由于住院和检测的增加,对某些类型的特殊袋(例如输液袋和检体采集袋)的需求激增,而由于择期手术的延迟和门诊就诊的减少,其他领域的需求有所下降。供应链和製造流程的中断也影响了特殊医疗袋的可得性,导致供不应求和物流挑战。此外,医疗机构对感染控制和安全的担忧日益增加,导致对一次性医疗产品(包括特种袋)的审查更加严格。
预计血袋细分市场将成为预测期内最大的细分市场
由于血袋的供应直接影响捐血计划和倡议,血袋市场预计将出现良好的成长。捐血中心和流动捐血站应随时提供血袋,以方便收集和储存捐血的血液。充足的血袋供应对于维持捐血计画的有效性和满足血液製品的需求至关重要,特别是在紧急情况和自然灾害期间,从而推动市场成长。
预计聚乙烯领域在预测期内复合年增长率最高
由于其多功能性、灵活性和对各种製造流程的适用性,预计聚乙烯领域在预测期内将出现最高的复合年增长率。聚乙烯可加工成多种形状,包括低密度聚乙烯(LDPE)、高密度聚苯乙烯(HDPE)和线型低密度聚乙烯(LLDPE),每种形状均可用于输液袋、引流袋、检体采集袋等,具有适合各类医用袋的特性。
由于人口老化推动了对医疗专用袋的需求,特别是用于管理慢性病和与老龄化相关的健康问题的医疗专用袋,预计亚太地区将在预测期内实现最大的增长,预计将占据市场占有率。。用于导尿管、造口护理、伤口处理和静脉治疗的专用袋在老年患者中需求量很大,促进了市场成长。
由于美国食品药物管理局(FDA) 和卫生署卫生部等机构实施严格的监管要求和品质标准,预计北美在预测期内的复合年增长率最高。对于特种医用袋製造商来说,遵守监管指南对于确保产品安全、有效和市场核准至关重要。
According to Stratistics MRC, the Global Medical Specialty Bags Market is accounted for $7.3 billion in 2024 and is expected to reach $10.9 billion by 2030 growing at a CAGR of 7.0% during the forecast period. Medical specialty bags are specialized containers used for the collection, storage, and transportation of various medical fluids, specimens, and waste in healthcare settings. These bags serve critical roles in patient care, infection control, and medical procedures. Common types of medical specialty bags include intravenous (IV) bags for administering fluids and medications, drainage bags for collecting urine or other bodily fluids, ostomy bags for managing waste from ostomy surgeries, and blood bags for collecting and storing blood donations or samples.
According to the World Health Organisation (WHO), 120 million units of blood are donated annually globally, and these blood storage and transfusion activities require blood bags.
Growing burden of chronic illnesses
Chronic illnesses often require ongoing management and treatment, leading to a rise in demand for home healthcare solutions. Medical specialty bags such as intravenous (IV) infusion bags, ostomy bags, and drainage bags play crucial roles in home-based care by facilitating fluid administration, waste management, and symptom relief. As more patients opt for home-based care to manage their chronic conditions, the demand for medical specialty bags grows correspondingly.
Cost concerns and reimbursement limitations
Reimbursement limitations and cost concerns can affect patient access to essential medical specialty bags, particularly for patients with chronic illnesses or complex medical needs. If healthcare facilities are unable to afford or procure necessary specialty bags due to financial constraints, patients may experience delays in treatment, suboptimal care, or barriers to accessing necessary medical interventions, potentially compromising their health outcomes.
Rising awareness and acceptance of home healthcare
The adoption of telemedicine and remote monitoring technologies has further facilitated the delivery of healthcare services in patients' homes. Medical specialty bags enable remote healthcare providers to monitor patients' vital signs, administer medications, and collect diagnostic samples from a distance, supporting the expansion of telehealth initiatives and improving access to healthcare for remote and underserved populations.
Disposal challenges and environmental concerns
Disposal challenges and environmental concerns may deter investment in research, development, and innovation within the medical specialty bags market. Manufacturers may be hesitant to introduce environmentally-friendly alternatives or invest in sustainable product design and materials if they perceive limited market demand or profitability, hindering market growth and stifling innovation.
Covid-19 Impact
While there was a surge in demand for certain types of specialty bags such as IV infusion bags and specimen collection bags due to increased hospitalizations and testing, other segments experienced declines as elective procedures were postponed and outpatient visits decreased. Disruptions in supply chains and manufacturing processes also affected the availability of medical specialty bags, leading to supply shortages and logistical challenges. Additionally, healthcare facilities faced heightened concerns about infection control and safety, leading to increased scrutiny of disposable medical products, including specialty bags.
The blood bags segment is expected to be the largest during the forecast period
The blood bags segment is estimated to have a lucrative growth, due to the availability of blood bags directly affects blood donation programs and initiatives. Blood bags need to be readily accessible to blood donation centers and mobile blood drives to facilitate the collection and storage of donated blood. Adequate supplies of blood bags are essential for maintaining blood donation programs' effectiveness and meeting the demand for blood products, particularly during emergencies or natural disasters driving the market growth.
The polyethylene segment is expected to have the highest CAGR during the forecast period
The polyethylene segment is anticipated to witness the highest CAGR growth during the forecast period, due to its versatility, flexibility, and compatibility with various manufacturing processes. It can be processed into different forms, including low-density polyethylene (LDPE), high-density polyethylene (HDPE), and linear low-density polyethylene (LLDPE), each offering specific properties suitable for different types of medical bags, such as IV infusion bags, drainage bags, and specimen collection bags.
Asia Pacific is projected to hold the largest market share during the forecast period owing to \ the region's aging population is driving demand for medical specialty bags, particularly those used in the management of chronic conditions and age-related health issues. Specialty bags for urinary catheters, ostomy care, wound management, and intravenous therapy are in high demand among elderly patients, contributing to market growth.
North America is projected to have the highest CAGR over the forecast period, as North America is subject to stringent regulatory requirements and quality standards enforced by agencies such as the Food and Drug Administration (FDA) in the United States and Health Canada. Compliance with regulatory guidelines is essential for manufacturers of medical specialty bags to ensure product safety, efficacy, and market approval.
Key players in the market
Some of the key players in the Medical Specialty Bags Market include Ambu AS, B Braun Medical, Baxter International Inc., C.R. Bard Inc, Cardinal Health Inc., Coloplast A/S, Convatec Inc., DuPont, Fresenius Medical Care AG & Co., Hollister Incorporated, Kawasumi Laboratories Inc., Macopharma, Medisave, Nolato AB, Pall Corporation, Persico S.p.a., Terumo Corporation, UNIFLEX HEALTHCARE, Versapak International Ltd and Westfield Medical Ltd.
In April 2024, Ambu announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) of its new generation duodenoscopy solution, Ambu(R) aScope(TM) Duodeno 2 and Ambu(R) aBox(TM) 2, for use in ERCP1 procedures.
In April 2024, Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S. Five new launches reinforce Baxter's focus on differentiated products and enhance the company's Pharmaceuticals portfolio in critical therapeutic areas
In April 2024, Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy. Offering the Novum IQ LVP in the U.S. demonstrates Baxter's commitment to continued innovation in advancing infusion therapy.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.